Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, February 10, 2010, 9:47pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares,
Register
FINANCE HOME PAGE
INVESTING
FINANCE NEWS
Enter symbol(s):
Market:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
|
Alphabetical List
Gen-Probe Inc. (GPRO)
At 5:00AM SGT:
43.19 USD
0.00 (0.00%)
MORE ON GPRO
Quotes
Summary
Options
Historical Prices
Charts
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
Gen-Probe Incorporated
(NasdaqNM:GPRO) Delayed quote data
Last Trade:
43.19 USD
Trade Time:
5:00AM SGT
Change:
0.00 (0.00%)
Prev Close:
43.19
Open:
N/A
Bid:
41.36
x 100
Ask:
45.64
x 100
1y Target Est:
49.23
Day's Range:
N/A - N/A
52wk Range:
35.70 - 49.29
Volume:
0
Avg Vol
(3m)
:
313,781
Market Cap:
2.12B
P/E
(ttm)
:
25.32
EPS
(ttm)
:
1.71
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
max
Use Y! Toolbar to track stocks
Add GPRO to Portfolio
Download Data
HEADLINES
Molecular Diagnostics Industry Creates New Sector With High Growth And Rapid Valuation Formation Characteristics For Investors According To Industry Expert
Wall Street Transcript
(Wed, Jan 27)
An In-Depth Look At Diagnostics Companies And Stock Evaluations From Dr. Ashim Anand Of Natixis Bleichroeder, LLC
Wall Street Transcript
(Mon, Jan 25)
Coverage initiated on Gen-Probe by Jefferies & Co
Briefing.com
(Thu, Jan 21)
Gen-Probe Earnings Call scheduled for Thu, Feb 18
CCBN
(Fri, Jan 15)
Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2009 Earnings Conference Call
Business Wire
(Fri, Jan 15)
Gen-Probe to Webcast Presentation at the 28th Annual J.P. Morgan Healthcare Conference
PR Newswire
(Wed, Jan 6)
Neogen Beats by a Penny
Zacks.com
(Wed, Dec 23)
Neogen 2Q profit rises on food safety sales
AP
(Sat, Dec 19)
4-Star Stocks on the Upswing
at Motley Fool
(Thu, Dec 17)
GEN PROBE INC Files SEC form 8-K, Other Events
EDGAR Online
(Wed, Dec 16)
Technical Setups: Frontline, Gen-Probe
at TheStreet.com
(Wed, Dec 16)
More Headlines for GPRO...
ANALYST
EPS Est (next year)
(Dec-09)
:
1.92
EPS Est (in 2 years)
(Dec-10)
:
2.17
Avg Rec (current)*:
2.1
PEG Ratio:
1.71
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
Gen-Probe Incorporated develops, manufactures, and markets nucleic acid probe-based products used for the clinical diagnosis of human diseases, and for screening donated human blood in North America and internationally.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
Latest News
Singapore Indices